137 related articles for article (PubMed ID: 35548968)
21. Perturbations in neuroinflammatory pathways are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors.
Miaskowski C; Topp K; Conley YP; Paul SM; Melisko M; Schumacher M; Chesney M; Abrams G; Levine JD; Kober KM
J Neuroimmunol; 2019 Oct; 335():577019. PubMed ID: 31401418
[TBL] [Abstract][Full Text] [Related]
22. Differential methylation and expression of genes in the hypoxia-inducible factor 1 signaling pathway are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors and with preclinical models of chemotherapy-induced neuropathic pain.
Kober KM; Lee MC; Olshen A; Conley YP; Sirota M; Keiser M; Hammer MJ; Abrams G; Schumacher M; Levine JD; Miaskowski C
Mol Pain; 2020; 16():1744806920936502. PubMed ID: 32586194
[TBL] [Abstract][Full Text] [Related]
23. Delayed recovery and increased severity of Paclitaxel-induced peripheral neuropathy in patients with diabetes.
de la Morena Barrio P; Conesa MÁ; González-Billalabeitia E; Urrego E; García-Garre E; García-Martínez E; Poves MZ; Vicente V; de la Peña FA
J Natl Compr Canc Netw; 2015 Apr; 13(4):417-23. PubMed ID: 25870378
[TBL] [Abstract][Full Text] [Related]
24. Cryotherapy for the prevention of weekly paclitaxel-induced peripheral adverse events in breast cancer patients.
Shigematsu H; Hirata T; Nishina M; Yasui D; Ozaki S
Support Care Cancer; 2020 Oct; 28(10):5005-5011. PubMed ID: 32036471
[TBL] [Abstract][Full Text] [Related]
25. Neurofilament light chain as a biomarker of axonal damage in sensory neurons and paclitaxel-induced peripheral neuropathy in patients with ovarian cancer.
Mortensen C; Steffensen KD; Simonsen E; Herskind K; Madsen JS; Olsen DA; Iversen DB; Bergmann TK; Pottegård A; Stage TB
Pain; 2023 Jul; 164(7):1502-1511. PubMed ID: 36508173
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of gabapentin for the prevention of paclitaxel induced peripheral neuropathy: A randomized placebo controlled clinical trial.
Aghili M; Zare M; Mousavi N; Ghalehtaki R; Sotoudeh S; Kalaghchi B; Akrami S; Esmati E
Breast J; 2019 Mar; 25(2):226-231. PubMed ID: 30773731
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness of gabapentin pharmacotherapy in chemotherapy-induced peripheral neuropathy.
Magnowska M; Iżycka N; Kapoła-Czyż J; Romała A; Lorek J; Spaczyński M; Nowak-Markwitz E
Ginekol Pol; 2018; 89(4):200-4. PubMed ID: 29781075
[TBL] [Abstract][Full Text] [Related]
28. Blood neurofilament light chain as a biomarker for monitoring and predicting paclitaxel-induced peripheral neuropathy in patients with gynecological cancers.
Kim SH; Kim KH; Hyun JW; Kim JH; Seo SS; Kim HJ; Park SY; Lim MC
Front Oncol; 2022; 12():942960. PubMed ID: 36059704
[TBL] [Abstract][Full Text] [Related]
29. Prospectively assessing serum neurofilament light chain levels as a biomarker of paclitaxel-induced peripheral neurotoxicity in breast cancer patients.
Karteri S; Bruna J; Argyriou AA; Mariotto S; Velasco R; Alemany M; Kalofonou F; Alberti P; Dinoto A; Velissaris D; Stradella A; Cavaletti G; Ferrari S; Kalofonos HP
J Peripher Nerv Syst; 2022 Jun; 27(2):166-174. PubMed ID: 35384143
[TBL] [Abstract][Full Text] [Related]
30. Alphalipoic Acid Prevents Oxidative Stress and Peripheral Neuropathy in Nab-Paclitaxel-Treated Rats through the Nrf2 Signalling Pathway.
Sun H; Guo X; Wang Z; Wang P; Zhang Z; Dong J; Zhuang R; Zhou Y; Ma G; Cai W
Oxid Med Cell Longev; 2019; 2019():3142732. PubMed ID: 30881589
[TBL] [Abstract][Full Text] [Related]
31. Increased risk of paclitaxel-induced peripheral neuropathy in patients using clopidogrel: a retrospective pilot study.
Matsuo M; Ito H; Takemura Y; Hattori M; Kawakami M; Takahashi N; Yamazaki M
J Anesth; 2017 Aug; 31(4):631-635. PubMed ID: 28451807
[TBL] [Abstract][Full Text] [Related]
32. Weekly Paclitaxel-Induced Neurotoxicity in Breast Cancer: Outcomes and Dose Response.
Timmins HC; Li T; Trinh T; Kiernan MC; Harrison M; Boyle F; Friedlander M; Goldstein D; Park SB
Oncologist; 2021 May; 26(5):366-374. PubMed ID: 33523545
[TBL] [Abstract][Full Text] [Related]
33. Genetic heterogeneity beyond CYP2C8*3 does not explain differential sensitivity to paclitaxel-induced neuropathy.
Hertz DL; Roy S; Jack J; Motsinger-Reif AA; Drobish A; Clark LS; Carey LA; Dees EC; McLeod HL
Breast Cancer Res Treat; 2014 May; 145(1):245-54. PubMed ID: 24706167
[TBL] [Abstract][Full Text] [Related]
34. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy.
Melli G; Taiana M; Camozzi F; Triolo D; Podini P; Quattrini A; Taroni F; Lauria G
Exp Neurol; 2008 Dec; 214(2):276-84. PubMed ID: 18809400
[TBL] [Abstract][Full Text] [Related]
35. An up-to-date view of paclitaxel-induced peripheral neuropathy.
Wu S; Xiong T; Guo S; Zhu C; He J; Wang S
J Cancer Res Ther; 2023 Dec; 19(6):1501-1508. PubMed ID: 38156915
[TBL] [Abstract][Full Text] [Related]
36. Comparison of sensory tests and neuronal quantity of peripheral nerves between streptozotocin (STZ)-induced diabetic rats and paclitaxel (PAC)-treated rats.
Jin HY; Lee NY; Ko HA; Lee KA; Park TS
Somatosens Mot Res; 2016; 33(3-4):186-195. PubMed ID: 27756190
[TBL] [Abstract][Full Text] [Related]
37. 7-Chloro-4-(Phenylselanyl) Quinoline Is a Novel Multitarget Therapy to Combat Peripheral Neuropathy and Comorbidities Induced by Paclitaxel in Mice.
Paltian JJ; Dos Reis AS; Martins AWS; Blödorn EB; Dellagostin EN; Soares LK; Schumacher RF; Campos VF; Alves D; Luchese C; Wilhelm EA
Mol Neurobiol; 2022 Oct; 59(10):6567-6589. PubMed ID: 35965270
[TBL] [Abstract][Full Text] [Related]
38. Concomitant Medications and Risk of Chemotherapy-Induced Peripheral Neuropathy.
Sánchez-Barroso L; Apellaniz-Ruiz M; Gutiérrez-Gutiérrez G; Santos M; Roldán-Romero JM; Curras M; Remacha L; Calsina B; Calvo I; Sereno M; Merino M; García-Donas J; Castelo B; Guerra E; Letón R; Montero-Conde C; Cascón A; Inglada-Pérez L; Robledo M; Rodríguez-Antona C
Oncologist; 2019 Aug; 24(8):e784-e792. PubMed ID: 30470691
[TBL] [Abstract][Full Text] [Related]
39. Peripheral neuropathy due to paclitaxel: study of the temporal relationships between the therapeutic schedule and the clinical quantitative score (QST) and comparison with neurophysiological findings.
Augusto C; Pietro M; Cinzia M; Sergio C; Sara C; Luca G; Scaioli V
J Neurooncol; 2008 Jan; 86(1):89-99. PubMed ID: 17611715
[TBL] [Abstract][Full Text] [Related]
40. Oral alpha-lipoic acid to prevent chemotherapy-induced peripheral neuropathy: a randomized, double-blind, placebo-controlled trial.
Guo Y; Jones D; Palmer JL; Forman A; Dakhil SR; Velasco MR; Weiss M; Gilman P; Mills GM; Noga SJ; Eng C; Overman MJ; Fisch MJ
Support Care Cancer; 2014 May; 22(5):1223-31. PubMed ID: 24362907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
